Ing C Olivetti SPA is now close to selling of its Olsy services subsidiary to Wang Laboratories Inc, according to UK press reports. The sale, first mooted last month (CI No 3,238) could be worth as much as $1bn, adding a huge $2.6bn of sales to Wang’s revenues. Olivetti would end up with a 19% stake in Wang, reports suggested.
This article is from the CBROnline archive: some formatting and images may not be present.
CBR Online legacy content.
Join our newsletter
Industry leading data and analysis for the FDI community